T. Simpatico

发表

The Birth of the Mind: How a Tiny Number of Genes Creates the Complexities of Human Thought

T. Simpatico, 2005 .

Quality of life: an approach integrating opportunities, human needs, and subjective well-being

Saleem H. Ali, Linda MacDonald Glenn, J. Farley, 2007 .

Clinical Practices that can Combat Endemic Legal Opioid Dependence: Genetic Addiction Risk Score (GARS)Ã¢ÂÂ¢, KB220ZÃ¢ÂÂ¢, Comprehensive Analysis of Reported Drugs (CARD) and Electrotherapy

K. Blum, M. Febo, T. Simpatico, 2013 .

Putative Dopamine Agonist (KB220Z) Attenuates Lucid Nightmares in PTSD Patients: Role of Enhanced Brain Reward Functional Connectivity and Homeostasis Redeeming Joy

K. Blum, M. Febo, M. Oscar-Berman, 2015, Journal of behavioral addictions.

The Addictive Brain: All Roads Lead to Dopamine

Thomas J. H. Chen, K. Blum, D. Barh, 2012, Journal of psychoactive drugs.

Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).

William B. Downs, Margaret A. Madigan, K. Blum, 2013, Journal of behavioral addictions.

Neurogenetics and Neurobiology of Dopamine in Anhedonia

K. Blum, M. Oscar-Berman, T. Simpatico, 2014 .

Staff perceptions about barriers to innovative behavioral rehabilitation programs

P. Corrigan, T. Simpatico, S. Mccracken, 1996, Cognitive Therapy and Research.

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?

K. Blum, P. Thanos, J. Cadet, 2022, Journal of personalized medicine.

Genetic Addiction Risk Score (GARS™) as a Predictor of Substance Use Disorder: Identifying Predisposition Not Diagnosis.

K. Blum, T. Simpatico, R. Badgaiyan, 2018, Current trends in medical diagnostic methods.

rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts

Yarong Wang, Yi Zhang, K. Blum, 2015, Postgraduate medicine.

Staff training to improve implementation and impact of behavioral rehabilitation programs.

P. Corrigan, T. Simpatico, S. Mccracken, 1997, Psychiatric services.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

William B. Downs, K. Blum, D. Barh, 2013, Journal of addiction research & therapy.

Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction

K. Blum, M. Febo, T. Simpatico, 2015, Journal of reward deficiency syndrome.

In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.

K. Blum, T. Simpatico, R. Badgaiyan, 2020, Current psychopharmacology.

Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

William B. Downs, K. Blum, D. Barh, 2012, Journal of addiction research & therapy.

A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain

Margaret A. Madigan, K. Blum, D. Barh, 2014, Journal of genetic syndromes & gene therapy.

Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech

K. Blum, P. Dumouchel, T. Quatieri, 2013, PloS one.

Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development.

K. Blum, P. Thanos, T. Simpatico, 2021, Current psychopharmacology.

Neurogenetics and nutrigenomics of reward deficiency syndrome (RDS): Stratification of addiction risk and mesolimbic nutrigenomic manipulation of hypodopaminergic function

Margaret A. Madigan, K. Blum, D. Barh, 2013 .

Systematic Evaluation of “Compliance” to Prescribed Treatment Medications and “Abstinence” from Psychoactive Drug Abuse in Chemical Dependence Programs: Data from the Comprehensive Analysis of Reported Drugs

K. Blum, M. Oscar-Berman, T. Simpatico, 2014, PloS one.

Significantly Attenuates Aberrant Mood in Residential Patient Addiction Treatment : Putative Activation of Dopaminergic Pathways in the MesoLimbic Reward Circuitry of Humans

Margaret A. Madigan, K. Blum, D. Barh, 2011 .

Kenneth Blum 1,5,6,8,10,11,12,15*, Marlene Oscar-Berman2, Elizabeth Stuller3, David Miller4,5, John Giordano6, Siobhan Morse6, Lee McCormick7, William Downs B5, Roger L Waite5, Debmalya Barh8, Dennis Neal9, Eric R Braverman1,10, Raquel Lohmann10, Joan Borsten11, Mary Hauser12, David Han13, Yijun Liu

K. Blum, D. Barh, M. Oscar-Berman, 2012 .

The mothers' project for homeless mothers with mental illnesses and their children: a pilot study.

T. Simpatico, D. Luchins, P. Hanrahan, 2005, Psychiatric rehabilitation journal.

Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and Reward Circuitry Natural Dopaminergic Activation.

K. Blum, D. Barh, M. Oscar-Berman, 2012, Journal of genetic syndromes & gene therapy.

Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis

K. Blum, P. Thanos, T. Simpatico, 2020 .

Nutrigenomics of Neuradaptogen Amino-Acid-Therapy and Neurometabolic Optimizers: Overcoming carbohydrate bingeing and overeating through neurometabolic mechanisms

Margaret A. Madigan, K. Blum, T. Simpatico, 2011 .

Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study.

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2013, Journal of addiction research & therapy.

Hypothesizing that Putative Dopaminergic, Melatonin, Benzodiazepine Reward Circuitry Receptor(s) Activator Provides Sleep Induction Benefits

Margaret A. Madigan, K. Blum, T. Simpatico, 2014 .

Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2013 .

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

Thomas J. H. Chen, K. Blum, M. Oscar-Berman, 2011, Molecular Neurobiology.

An Integrative Approach to Quality of Life Measurement, Research, and Policy

Saleem H. Ali, Linda MacDonald Glenn, J. Farley, 2008 .

Vermont responds to its opioid crisis.

T. Simpatico, 2015, Preventive medicine.

Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms.

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2012, Journal of genetic syndromes & gene therapy.

Coupling Neurogenetics ( GARS TM ) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome ( RDS ) : Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms Journal of Reward Deficiency Syndrome

Febo, K. Blum, T. Simpatico, 2016 .

Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms

K. Blum, M. Febo, T. Simpatico, 2015, Journal of reward deficiency syndrome.

Hypothesizing Benefits of the Incorporation of Genetic Addiction Risk Score (GARSRX™Rx™) and Dopamine Agonist Modalities (DAM) in Clinical Addiction Medicine.

K. Blum, M. Febo, T. Simpatico, 2014 .

NEUROGENETIC IMPAIRMENTS OF BRAIN REWARD CIRCUITRY LINKS TO REWARD DEFICIENCY SYNDROME (RDS) AS EVIDENCED BY GENETIC ADDICTION RISK SCORE (GARS): A CASE STUDY

Margaret A. Madigan, K. Blum, D. Barh, 2013 .

Translational Research to Uncover Diagnostic & Therapeutic Gene Targets Emerging in a Genomic Era: from Bench to Bedside

K. Blum, T. Simpatico, E. Braverman, 2012 .

Disorders & Genetic Reports

K. Blum, T. Simpatico, J. Giordano, 2012 .

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.

K. Blum, M. Febo, M. Oscar-Berman, 2016 .

Personality-Disordered Patients: Treatable and Untreatable

T. Simpatico, 2007 .

A self-assessment program for multidisciplinary mental health teams.

T. Simpatico, C. Stout, L. Grossman, 2001, Psychiatric services.

Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech

K. Blum, D. Barh, P. Dumouchel, 2013, PLoS ONE.

Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs

K. Blum, M. Febo, M. Oscar-Berman, 2016, Molecular Neurobiology.

Audio Therapy Significantly Attenuates Aberrant Mood in Residential Patient Addiction Treatment: Putative Activation of Dopaminergic Pathways in the Meso-Limbic Reward Circuitry of Humans

Margaret A. Madigan, K. Blum, D. Barh, 2013 .

Neuropsychiatric Genetics of Happiness, Friendships and Politics: A New Era in Understanding Social Interface

K. Blum, T. Simpatico, E. Braverman, 2012 .

Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™

Margaret A. Madigan, K. Blum, D. Barh, 2013, Journal of genetic syndromes & gene therapy.

Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.

K. Blum, M. Oscar-Berman, T. Simpatico, 2012, Journal of genetic syndromes & gene therapy.

Tie a Knot and Hang On: Providing Mental Health Care in a Turbulent Environment

T. Simpatico, 2006 .

Perspectives An integrative approach to quality of life measurement , research , and policy

Saleem H. Ali, Linda MacDonald Glenn, J. Farley, 2016 .